期刊文献+

磁性壳聚糖微球制备及生物相容性的研究 被引量:4

Preparation and biocompatibility of magnetic chitosan microspheres
原文传递
导出
摘要 目的:制备5-氟尿嘧啶磁性壳聚糖微球并评价空载磁性壳聚糖微球的生物相容性。方法:采用乳化交联法制备5-氟尿嘧啶磁性壳聚糖微球并优化制备工艺,采用扫描电镜和振动样品磁强计(VSM)对微球进行表征;四噻唑蓝法观察细胞增殖情况,评估磁性壳聚糖微球的体外细胞毒性;溶血实验和血常规检查评估磁性壳聚糖微球的血液相容性;植埋实验评估磁性壳聚糖微球的组织相容性。结果:经过优化后的5-氟尿嘧啶磁性壳聚糖微球包封率和载药量分别为70.2%和12.3%,Z-均粒径为1 479.6 nm,饱和磁化度为4.79 emu.g-1,微球形态良好、均匀圆整;自制空载磁性壳聚糖微球体外细胞相容性符合要求,显示出良好的血液相容性和体内组织相容性。结论:优化了5-氟尿嘧啶磁性壳聚糖微球的制备工艺,制备的空载磁性壳聚糖微球具有很好的生物相容性。 Objective: To prepare 5-fluorouracil-loaded magnetic chitosan microspheres and to estimate the biocompatibility of unloaded magnetic chitosan mierospheres. Methods: 5-Fluorouracil-loaded magnetic chitosan microspheres were established by emulsification cross-linking method and the preparation procedure was optimized. The obtained magnetic mierospheres were characterized by scanning electron microscopy and VSM. MTT assay was used to evaluate the in vitro cytotoxicity test. Haemolysis test and blood routine examination were used to evaluate blood compatibility. The implantation test was used to evaluate histoeompatibility. Results: Encapsulation efficien- cy and loading efficiency of 5-fluorouracil in magnetic chitosan microspheres reached 70.2% and 12.3% after opti- mization. The Z-average diameter was 1 479.6 nm. The saturation magnetization is 4.79 emu. g-1 The micro- spheres were spherical shape with a regular surface. Compatibility of unloaded magnetic chitosan microspheres was in coincidence with the criteria. Conclusion: The optimized preparation condition is confirmed and repeated. Un- loaded magnetic chitosan microspheres has a superior biocompatibility.
出处 《中国新药杂志》 CAS CSCD 北大核心 2013年第2期221-225,243,共6页 Chinese Journal of New Drugs
关键词 壳聚糖 磁性微球 相容性 5-氟尿嘧啶 chitosan magnetic microspheres compatibility 5-fluorouracil
  • 相关文献

参考文献11

  • 1郑爱萍,刘海宏,李宏斌,武凤兰.5-氟脲嘧啶壳聚糖微球的制备及体外释放特性[J].中国药科大学学报,2004,35(4):318-323. 被引量:30
  • 2Malet-Martino M,Martino R.Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review[].The Oncologist.2002
  • 3JoséL Arias,Visitación Gallardo,M Adolfina Ruiz et al.Magnetite/poly (alkylcyanoacrylate) (core/shell)nanoparticles as5-Fluorouracil deliv-ery systems for active targeting[].European Journal of Pharmaceutics and Biopharmaceutics.2008
  • 4Can ZH,Yao C,Qu GW ,et al.Preparation and characterization ofgalacl08ylatedchit08an coated BSA microspheres contsining 5-fluorouracil[].JCarbohydrate Polymer.2008
  • 5Sun Y,Gu L,Gao YA,et al.Preparation and Characterization of 5-Fluorouracil Loaded Chitosan Microspheres by a Two-Step Solidification Method[].Chemical and Pharmaceutical Bulletin.2010
  • 6Guo L,Liu G,Hong R Y,et al.Preparation and characterization ofchitosan poly(acrylic acid)magnetic microspheres[].MarDrugs.2010
  • 7Xu, Z,Zhang, J,Meng, L,Song, J,Qiao, X.Preparation and characterization of magnetic chitosan microsphere sorbent for separation and determination of environmental estrogens through SPE coupled with HPLC[].Journal of Separation Science.2011
  • 8Fu YJ,Shyu SS,Su FH,et al.Development of biodegradable co-poly(d,l-lactic/glycolic acid) microspheres for the controlled release of 5-FU by the spray drying method[].Colloids and Surfaces.2002
  • 9HUANG LL,SUI WP,WANG YX,et al.Preparation of chitosan/chondroitin sulfate complex microcapsules and application in con-trolled release of 5-fluorouracil[].Carbohydrate Polymers.2010
  • 10ZHANG X,CHEN F,NI J.A novel method to prepare magnetitechitosan microspheres conjugated with methotrexate (MTX)forthe controlled release of MTX as a magnetic targeting drug deliv-ery system[].Drug Delivery.2009

二级参考文献7

  • 1Sakane T,Yamashita S,Yata H,et al.Transnasal delivery of 5-fluorouracil to the brain in the rat[J].J Drug Targeting,1999,7(3):233-239.
  • 2Lim ST,Mrtin GP,Berry DJ,et al.Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan[J].J of Controlled Release,2000,66:281-292.
  • 3Denkbas EB,Seyyal M,Piskin E.Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning[J].J of Membrane Science,2000,172:33-38.
  • 4Illum L,Jorgensed H,Bisgaard H,et al.Bioadhesive microspheres as a potential nasal drug delivery system[J].Int J Pharm,1987,39(3):189-195.
  • 5Sheu MT,Sokoloski TD.Entrapment of bioactive compounds within native albumin beads:Ⅲ.Evaluation of parameters affecting drug release[J].J Parenter Sci Technol,1986,40(6):259-266.
  • 6丁明,孙虹,康玲,陶枝,施建军,皇甫立霞,高建峰.壳聚糖微球的制备研究[J].合肥联合大学学报,1998(2):7-11. 被引量:6
  • 7兰传青,刘正坤.蛋白微球制备过程中诸影响因素的最佳水平的选择研究[J].国外医药(合成药.生化药.制剂分册),1992,13(2):103-104. 被引量:7

共引文献29

同被引文献29

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部